700 Shares in Colgate-Palmolive (NYSE:CL) Purchased by Arlington Trust Co LLC

Arlington Trust Co LLC acquired a new stake in Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 700 shares of the company’s stock, valued at approximately $56,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. &PARTNERS lifted its position in Colgate-Palmolive by 0.7% in the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after purchasing an additional 129 shares during the last quarter. West Branch Capital LLC lifted its position in Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares during the last quarter. Gladstone Institutional Advisory LLC lifted its position in Colgate-Palmolive by 2.1% in the first quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock valued at $476,000 after purchasing an additional 133 shares during the last quarter. First Foundation Advisors lifted its position in Colgate-Palmolive by 2.7% in the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after purchasing an additional 136 shares during the last quarter. Finally, Waldron Private Wealth LLC lifted its position in Colgate-Palmolive by 2.7% in the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after purchasing an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on CL shares. UBS Group increased their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a report on Monday, January 29th. Barclays increased their target price on Colgate-Palmolive from $75.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 16th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Finally, JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $87.31.

Colgate-Palmolive Trading Up 0.5 %

Colgate-Palmolive stock opened at $87.88 on Monday. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37. The stock has a market capitalization of $72.24 billion, a PE ratio of 31.61, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The business’s fifty day moving average is $86.61 and its 200 day moving average is $79.86.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. During the same period last year, the firm posted $0.77 earnings per share. Colgate-Palmolive’s revenue was up 6.9% compared to the same quarter last year. On average, sell-side analysts predict that Colgate-Palmolive will post 3.49 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a $0.50 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is 69.06%.

Insider Transactions at Colgate-Palmolive

In related news, insider Jennifer Daniels sold 61,633 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the sale, the insider now owns 57,948 shares of the company’s stock, valued at approximately $4,863,575.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Jennifer Daniels sold 61,633 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the sale, the insider now owns 57,948 shares of the company’s stock, valued at approximately $4,863,575.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gregory Malcolm sold 8,930 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $85.35, for a total value of $762,175.50. Following the sale, the executive vice president now directly owns 8,043 shares in the company, valued at approximately $686,470.05. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 over the last quarter. 0.37% of the stock is currently owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.